Revised forecast
Fiscal year ending March 2027 · Six months and full yearPrevious forecast published 13 May 2026The bar length represents the relative magnitude of change, based on the item that changed the most in this document. The percentage change shown by the dotted line is calculated from the two reported figures because the company did not provide the rate.
The interim period exceeded the previous forecast due to growth in existing transactions, the acquisition of new business, securing materials ahead of schedule, and price revisions in the Chemical Business segment. For the full year, the full-year forecast has been revised upward after incorporating the expectation that results from the third quarter onward will fall below the previous forecast due in part to the unwinding of advance materials procurement in light of the situation in the Middle East.
| Item | Details |
|---|---|
| Net Sales | 2Q cumulative 13,280 / Full year 28,000 → Cumulative through the second quarter (current results) 14,921 / Full year 29,000（2Q cumulative 12.4 / Full year 3.6） |
| Operating profit | 2Q cumulative 174 / Full year 528 → Cumulative through the second quarter (current results) 298 / Full year 530（2Q cumulative 71.3 / Full year 0.4） |
| Ordinary income | 2Q cumulative 225 / Full year 608 → Cumulative through the second quarter (current results) 371 / Full year 630（2Q cumulative 64.9 / Full year 3.6） |
| Profit attributable to owners of the parent | 2Q cumulative 136 / Full year 391 → Cumulative through the second quarter (current results) 253 / Full year 420（2Q cumulative 86 / Full year 7.4） |
| Net income per share | 2Q cumulative 151.09 / Full year 434.40 → Cumulative through the second quarter (current results) 280.96 / Full year 466.05 |
| Fiscal Period Covered | Fiscal year ending March 2027 |
| Period Covered | Six months and full year |
| Publication date of previous forecast | 13 May 2026 |
| Previous-period results | 2Q cumulative Revenue ¥13,277 million, operating profit ¥230 million, ordinary profit ¥293 million, interim net income attributable to owners of the parent ¥475 million, interim net income per share ¥527.75 / Full year Revenue ¥27,199 million, operating profit ¥513 million, ordinary profit ¥628 million, net income attributable to owners of the parent ¥752 million, net income per share ¥836.79 |
| Reason for the revision | The interim period exceeded the previous forecast due to growth in existing transactions, the acquisition of new business, securing materials ahead of schedule, and price revisions in the Chemical Business segment. For the full year, the full-year forecast has been revised upward after incorporating the expectation that results from the third quarter onward will fall below the previous forecast due in part to the unwinding of advance materials procurement in light of the situation in the Middle East. |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (2)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.During the interim period, the Building and Finishing Materials Business segment struggled because shipments of housing-related products and other items remained sluggish. Meanwhile, the Chemical Business segment saw a substantial increase in revenue and profit, driven by growth in existing transactions, the acquisition of new business, securing materials ahead of schedule, and price revisions. For the full year, the forecasts have been revised upward after incorporating the interim results, which exceeded expectations, as well as the expectation that results from the third quarter onward will fall below the previous forecasts due in part to the unwinding of advance materials procurement in light of the situation in the Middle East.